Diagens Maintains Stable Share Base and Public Float Compliance in July 2026

Bulletin Express08-03 16:52

Hangzhou Diagens Biotechnology Co., Ltd. (DIAGENS-B) reported no changes in registered or issued share capital for the month ended 31 July 2026, according to its monthly return filed with Hong Kong Exchanges and Clearing on 3 August 2026.

The company’s registered share capital remained at 88.88 million ordinary H shares with a par value of RMB 1 each, equivalent to registered share capital of RMB 88.88 million. Issued shares totaled the same 88.88 million, with zero treasury shares outstanding, reflecting no share issuances, cancellations, or repurchases during the month.

Diagens confirmed that it continued to meet the Hong Kong Main Board’s minimum public-float requirement, which was set at 17.05% of issued H shares at the time of listing.

No activity was recorded under share option schemes, warrants, convertible securities, or other equity-linked arrangements, underscoring a stable capital structure over the reporting period.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1161781030?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-03 16:52","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1161781030","market":"us","top_or_hot":-1,"title":"Diagens Maintains Stable Share Base and Public Float Compliance in July 2026","media":"Bulletin Express","content":"<p>Hangzhou Diagens Biotechnology Co., Ltd. (DIAGENS-B) reported no changes in registered or issued share capital for the month ended 31 July 2026, according to its monthly return filed with Hong Kong Exchanges and Clearing on 3 August 2026.</p>\n<p>The company’s registered share capital remained at 88.88 million ordinary H shares with a par value of RMB 1 each, equivalent to registered share capital of RMB 88.88 million. Issued shares totaled the same 88.88 million, with zero treasury shares outstanding, reflecting no share issuances, cancellations, or repurchases during the month.</p>\n<p>Diagens confirmed that it continued to meet the Hong Kong Main Board’s minimum public-float requirement, which was set at 17.05% of issued H shares at the time of listing.</p>\n<p>No activity was recorded under share option schemes, warrants, convertible securities, or other equity-linked arrangements, underscoring a stable capital structure over the reporting period.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Diagens Maintains Stable Share Base and Public Float Compliance in July 2026</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDiagens Maintains Stable Share Base and Public Float Compliance in July 2026\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-03 16:52</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Hangzhou Diagens Biotechnology Co., Ltd. (DIAGENS-B) reported no changes in registered or issued share capital for the month ended 31 July 2026, according to its monthly return filed with Hong Kong Exchanges and Clearing on 3 August 2026.</p>\n<p>The company’s registered share capital remained at 88.88 million ordinary H shares with a par value of RMB 1 each, equivalent to registered share capital of RMB 88.88 million. Issued shares totaled the same 88.88 million, with zero treasury shares outstanding, reflecting no share issuances, cancellations, or repurchases during the month.</p>\n<p>Diagens confirmed that it continued to meet the Hong Kong Main Board’s minimum public-float requirement, which was set at 17.05% of issued H shares at the time of listing.</p>\n<p>No activity was recorded under share option schemes, warrants, convertible securities, or other equity-linked arrangements, underscoring a stable capital structure over the reporting period.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02526","symbol_name":"德适-B","start_time":0,"source_url":"","article_id":"1161781030","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1161781030","pubTimestamp":1785747127,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Hangzhou Diagens Biotechnology Co., Ltd. (DIAGENS-B) reported no changes in registered or issued share capital for the month ended 31 July 2026, according to its monthly return filed with Hong Kong...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02526":"德适-B"},"translate_title":"Diagens 在 2026 年 7 月保持稳定的份额基础和公众持股量合规性","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02526":1},"content_text":"Hangzhou Diagens Biotechnology Co., Ltd. (DIAGENS-B) reported no changes in registered or issued share capital for the month ended 31 July 2026, according to its monthly return filed with Hong Kong Exchanges and Clearing on 3 August 2026.\nThe company’s registered share capital remained at 88.88 million ordinary H shares with a par value of RMB 1 each, equivalent to registered share capital of RMB 88.88 million. Issued shares totaled the same 88.88 million, with zero treasury shares outstanding, reflecting no share issuances, cancellations, or repurchases during the month.\nDiagens confirmed that it continued to meet the Hong Kong Main Board’s minimum public-float requirement, which was set at 17.05% of issued H shares at the time of listing.\nNo activity was recorded under share option schemes, warrants, convertible securities, or other equity-linked arrangements, underscoring a stable capital structure over the reporting period.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1161781030","isCrawlerRequest":true}